ZELENECTIDE PEVEDOTIN
UNII 0IN1TZ844E

Substance Identification & Data

This profile provides standardized clinical and technical data for Zelenectide Pevedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0IN1TZ844E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2407446-48-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

0IN1TZ844E

CAS Registry Number

2407446-48-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZELENECTIDE PEVEDOTIN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C178397

National Cancer Institute reference terminology for clinical and research data.

INN ID

12680

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-142

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zelenectide Pevedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZELENECTIDE PEVEDOTIN

ZELENECTIDE PEVEDOTIN [INN]

Common Names & Synonyms

BT 8009 [WHO-DD]

ZELENECTIDE PAVEDOTIN [USAN]

Systematic Nomenclature

L-CYSTEINE, N-(4-CARBOXY-1-OXOBUTYL)-.BETA.-ALANYL-N-METHYLGLYCYL-N-METHYLGLYCYL-N-METHYLGLYCYL-N-METHYLGLYCYL-N-METHYLGLYCYL-N-METHYLGLYCYL-N-METHYLGLYCYL-N-METHYLGLYCYL-N-METHYLGLYCYL-N-METHYLGLYCYL-S-(3-OXO-3-(TETRAHYDRO-3,5-BIS(3-MERCAPTO-1-OXOPROPYL)-1,3,5-TRIAZIN-1(2H)-YL)PROPYL)-L-CYSTEINYL-L-PROLYL-3-(1-NAPHTHALENYL)-L-ALANYL-D-.ALPHA.-ASPARTYL-L-CYSTEINYL-L-METHIONYL-N6-(AMINOIMINOMETHYL)-L-LYSYL-L-.ALPHA.-ASPARTYL-L-TRYPTOPHYL-L-SERYL-L-THREONYL-L-PROLYL-(4R)-4-HYDROXY-L-PROLYL-L-TRYPTOPHYL-, CYCLIC (12->16),(12->26)-BIS(THIOETHER), (1->1')-AMIDE WITH N-METHYL-N-(((4-((L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE

SYS